Skip to main content
Log in

Hepatitis C virus genotypes are not responsible for development of serious liver disease

  • Originals Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Although hepatitis C virus (HCV) is known to have at least four kinds of genotypes, no clear relationship has yet been established between the genotype and the severity of liver disease. Therefore, we determined HCV genotypes in sera of 251 Japanese patients with type C chronic liver disease, using polymerase chain reactions with six independent primers. One set of primers and a probe derived from 5′-noncoding region of HC-J1 was supposed to detect all four genotypes, while the other five were devised to detect each of the genotypes. Among the patients, the major genotype was type II (69%) and the second most common was type III (18%). Type IV was found in 7%, while none had type I genotype. There was no significant difference in the distribution of any genotype among different stages of liver disease, although the ratio of type II to type III tended to be higher in the group of cirrhosis and hepatocellular carcinoma than in the chronic hepatitis group (5.5 vs 3.0). The amounts of HCV RNA were significantly greater in patients with type II (P<0.001) compared with those with types III and IV. However, HCV concentrations of each genotype were not associated with the disease status. These results suggest that HCV genotypes are unlikely to be responsible for the development of more serious liver disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362, 1989

    Google Scholar 

  2. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M: An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364, 1989

    Google Scholar 

  3. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ: Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12:671–675, 1990

    Google Scholar 

  4. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo Q-L, Houghton M, Kuo G: Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6547–6549, 1990

    Google Scholar 

  5. Hasan F, Jeffers LJ, Medina MD, Reddy KR, Parker T, Schiff ER, Houghton M, Choo Q, Kuo G: Hepatitis C-associated hepatocellular carcinoma. Hepatology 12:589–591, 1990

    Google Scholar 

  6. Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, Craxi A, Ciccaglione A, Giuseppetti R, Stroffolini T, Pagliaro L: Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med 116:97–102, 1992

    Google Scholar 

  7. Lok ASF, Cheung R, Chan R, Liu V: Hepatitis C viremia in patients with hepatitis C virus infection. Hepatology 15:1007–1012, 1992

    Google Scholar 

  8. Houghton M, Weiner A, Han J, Kuo G, Choo Q-L: Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease. Hepatology 14:381–387, 1991

    Google Scholar 

  9. Enomoto N, Takada A, Nakao T, Date T: There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 170:1021–1025, 1990

    Google Scholar 

  10. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M: Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 73:673–679, 1992

    Google Scholar 

  11. Cha TA, Beall E, Irvine B, Kolberg J, Chien D, Kuo G, Urdea MS: At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci USA 89:7144–7148, 1992

    Google Scholar 

  12. Takada N, Takase S, Takada A, Date T: HCV genotypes in different countries. Lancet 339:808, 1992

    Google Scholar 

  13. Pozzato G, Moretti M, Franzin F, Croce LS: Severity of liver disease with different hepatitis C viral clones. Lancet 338:509, 1991

    Google Scholar 

  14. Takada N, Takase S, Enomoto N, Takada A, Date T: Clinical backgrounds of patients having different types of hepatitis C virus genomes. J Hepatol 14:35–40, 1992

    Google Scholar 

  15. Kanai K, Kako M, Okamoto H: HCV genotypes in chronic hepatitis C and response to interferon. Lancet 339:1543, 1992

    Google Scholar 

  16. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T: Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: Relationship to genotypes of hepatitis C virus. Hepatology 16:293–299, 1992

    Google Scholar 

  17. International Group: Acute and chronic hepatitis revisited. Lancet 2:914–919, 1977

    Google Scholar 

  18. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159, 1987

    Google Scholar 

  19. Okamoto H, Okada S, Sugiyama Y, Yotsumoto S, Tanaka T, Yoshizawa H, Tsuda F, Miyakawa Y, Mayumi M: The 5′-terminal sequence cf hepatitis C virus genome. Jpn J Exp Med 60:167–177, 1990

    Google Scholar 

  20. Kubo Y, Takeuchi K, Boonmar S, Katayama T, Choo Q-L, Kuo G, Weiner AJ, Bradley DW, Houghton M, Saito I, Miyamura T: A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan. Nucleic Acids Res 17:10367–10372, 1989

    Google Scholar 

  21. Choo Q-L, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby A, Barr PJ, Weiner AJ, Bradler DW, Kuo G, Houghton M: Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451–2455, 1991

    Google Scholar 

  22. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N: Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350–1354, 1985

    Google Scholar 

  23. Gilliland G, Perrin S, Blanchard K, Bunn HF: Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 87:2725–2729, 1990

    Google Scholar 

  24. Causse X, Godinot H, Chevallier M, Chossegros P, Zoulim F, Ouzan D, Heyraud JP, Fontanges T, Albrecht J, Meschievitz C, Trepo C: Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 101:497–502, 1991

    Google Scholar 

  25. Camma C, Craxi A, Tine F, Almasio P, Di Marco V, Lo Lacomo O, Bruno R, Fiorello F, Pagliaro L: Predictors of response to alpha-interferon (IFN) in chronic hepatitis C: A multivariate analysis on 361 treated patients. Hepatology 16:131A, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamada, M., Kakumu, S., Yoshioka, K. et al. Hepatitis C virus genotypes are not responsible for development of serious liver disease. Digest Dis Sci 39, 234–239 (1994). https://doi.org/10.1007/BF02090191

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02090191

Key words

Navigation